Charles Polsky, MD ’96. Photo by Lloyd DeGrane Charles Polsky’s transition from medicine to finance reflects an unconventional path, but one that makes him particularly well suited to act as a resource to the University of Chicago’s promising inventors and… Keep reading
Dr. Elliott Sigal (MD’81, PhD), President of R&D;, Bristol-Myers Squibb, and Dr. Michael Prystowsky (MD’81, PhD), Chairman of Pathology, Albert Einstein College of Medicine, participate in the inaugural event of the new UChicago Mid-Atlantic Bio-Life Sciences Alumni Group. Photos… Keep reading
Godfrey Getz, M.D., Catherine Reardon, and Geoffrey Wool. In the vanguard of a new generation of promising drug therapies for treating atherosclerosis with “good” cholesterol (high density lipoprotein, or HDL) is an agent being developed by Godfrey Getz, MD, PhD,… Keep reading
Karen Kerr, PhD ’95. Photo by Beth Rooney It’s no surprise that Intellectual Ventures, a leading global investor in inventions, hired Karen Kerr, PhD, to forge relationships with universities doing innovative translational research. After all, the recently appointed… Keep reading
Martin E. Sanders, MD, ’79. Photo by Lloyd DeGrane A few years ago, University of Chicago alumnus Martin E. Sanders, MD ’79, attended a “meet and greet” in San Francisco that was held to introduce the University’s new … Keep reading
Luping Yu and Yongye Liang. Photo by Lloyd DeGrane Solarmer Energy Inc. is developing plastic solar cells for portable electronic devices that will incorporate technology invented at the University of Chicago. The company is on track to complete a commercial-grade… Keep reading
Ken Bradley. Photo by Lloyd DeGrane Arryx, a company based on technology invented at the University of Chicago that still has strong ties with the University, is poised to help Haemonetics, the world’s largest… Keep reading
Laurens Mets, PhD. Photo by Lloyd DeGrane Generating electrical power from the sun and the wind share a common drawback: The sun does not always shine and the wind does not always blow when and where the electricity is needed. Keep reading
Time. Treasure. Talent. That’s what alumni should give back to their schools, according to Doug Given, an Investment Partner at Bay City Capital and longtime advisor to UChicagoTech—the University of Chicago’s Office of Technology and Intellectual Property. Given earned a PhD’79… Keep reading
Daphne Preuss, PhD On August 20, Chromatin—a company that grew out of research at the University of Chicago—announced that it had entered into a technological alliance and license agreement with Bayer CropScience. Under the agreement, Bayer CropScience has obtained non-exclusive… Keep reading
Patrick Singleton and Frances Lennon. Photo by Lloyd DeGrane UChicagoTech, the University of Chicago’s Office of Technology and Intellectual Property, recently conducted its second in a series of Translation Events that bring industry experts to campus to advise faculty members… Keep reading
Rifat Pamukcu and John Alverdy. Photos by Lloyd DeGrane By the end of the year, Midway Pharmaceuticals expects to have successfully navigated the “Valley of Death.” That’s the period of financing between identifying a drug product candidate and getting it… Keep reading